GlassScriptPhysician profile
Melinda Munson
NPI 1659352243
$1,124.74
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $119 · 2021: $239 · 2022: $172 · 2023: $290 · 2024: $21.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $311.27 | 2019-2023 | |
| Daiichi Sankyo INC. | $78.67 | 2021-2024 | Injectafer |
| Renovia INC | $73.26 | 2019 | |
| Pfizer INC. | $66.84 | 2023 | |
| Therapeuticsmd, INC. | $57.83 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $57.20 | 2019 | |
| Myovant Sciences INC. | $56.16 | 2021-2022 | |
| Exeltis, USA INC. | $51.07 | 2019-2023 | Slynd |
| Avion Pharmaceuticals | $50.84 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.02 | 2020-2023 | |
| Coopersurgical, INC. | $41.08 | 2020-2023 | Summit Doppler |
| Lupin INC. | $39.74 | 2019-2020 | |
| Shield Therapeutics INC | $34.66 | 2023 | Accrufer |
| Mission Pharmacal Company | $28.83 | 2019 | |
| Minerva Surgical, INC | $21.74 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $17.78 | 2023 | Myfembree |
| Millicent US INC | $16.20 | 2019 | |
| Merck Sharp & Dohme LLC | $16.02 | 2019 | |
| Coloplast Corp | $13.78 | 2019 | |
| Aspira Women'S Health INC | $13.19 | 2023 | Ova1 |
| Evofem Biosciences, INC. | $11.98 | 2021 | |
| Scynexis, INC. | $11.93 | 2022 | |
| Duchesnay USA Incorporated | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melinda Munson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.